Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia

Published:2016-10-24 Issue:5 Volume:31 Page:1177-1186
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Lohmann G,Vasyutina E,Bloehdorn J,Reinart N,Schneider J I,Babu V,Knittel G,Crispatzu G,Mayer P,Prinz C,Muenzner J K,Biersack B,Efremov D G,Chessa L,Herling C D,Stilgenbauer S,Hallek M,Schobert R,Reinhardt H C,Schumacher B,Herling M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/leu2016294.pdf

Reference54 articles.

1. Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010; 376: 1164–1174.

2. Cramer P, Langerbeins P, Eichhorst B, Hallek M . Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG). Eur J Haematol 2016; 96: 9–18.

3. Farooqui MZH, Valdez J, Martyr S, Aue G, Saba N, Niemann CU et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol 2015; 16: 169–176.

4. Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med 2013; 369: 32–42.

5. Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F . The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009; 114: 3367–3375.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells;Molecules;2023-07-02

2. Moringa oleifera Leaf Ethanol Extract Immunomodulatory Activity Discriminates between Chronic Myeloid Leukaemia Cell Line and Normal Lymphocytes;LABORATORY R_T;2022-12-12

3. Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma;Cancer Letters;2021-03

4. NF-κB–induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia;Proceedings of the National Academy of Sciences;2021-03-01

5. N-Metallocenoylsphingosines as targeted ceramidase inhibitors: Syntheses and antitumoral effects;Bioorganic Chemistry;2020-04